ALK-Abelló
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
ALK | CO
Overview
Corporate Details
- ISIN(s):
- DK0061802139
- LEI:
- 529900SGCREUZCZ7P020
- Country:
- Denmark
- Address:
- Bøge Alle 6-8, 2970 Hørsholm
- Website:
- https://www.alk.net
- Sector:
- Manufacturing
Description
ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2016-01-15 17:34 |
Meddelelse om ejerskab i ALK
|
English | PDF • 21.3 KB | ||
| 2016-01-14 17:05 | Danish | TXT • 8.7 KB | |||
| 2016-01-14 17:05 | English | PDF • 49.0 KB | |||
| 2016-01-14 17:05 |
ALK offentliggør hovedresultater fra det femårige GRAZAX® Asthma Prevention (GA…
|
English | TXT • 8.6 KB | ||
| 2016-01-14 17:05 |
ALK offentliggør hovedresultater fra det femårige GRAZAX® Asthma Prevention (GA…
|
English | PDF • 63.6 KB | ||
| 2016-01-06 17:24 | English | TXT • 3.2 KB | |||
| 2016-01-06 17:24 | Danish | TXT • 3.3 KB | |||
| 2016-01-06 17:24 |
ALK opjusterer sine finansielle forventninger til 2015 som følge af salgsudvikl…
|
English | PDF • 36.4 KB | ||
| 2016-01-06 17:24 |
ALK opjusterer sine finansielle forventninger til 2015 som følge af salgsudvikl…
|
English | PDF • 36.0 KB | ||
| 2015-12-25 09:00 | English | TXT • 3.9 KB | |||
| 2015-12-25 09:00 | English | PDF • 31.9 KB | |||
| 2015-12-25 09:00 |
ALKs partner, Torii, indsender registreringsansøgning for tabletvaccine mod ced…
|
English | TXT • 3.6 KB | ||
| 2015-12-25 09:00 |
ALKs partner, Torii, indsender registreringsansøgning for tabletvaccine mod ced…
|
English | PDF • 32.3 KB | ||
| 2015-12-21 09:49 | Danish | TXT • 2.4 KB | |||
| 2015-12-21 09:49 | English | PDF • 22.4 KB |
Automate Your Workflow. Get a real-time feed of all ALK-Abelló filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ALK-Abelló
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ALK-Abelló via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
